Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHARP: Simvastatin + Ezetimibe in CKD
NCT00125593Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Jun 2003
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic kidney disease (CKD) comparing Placebo, Simvastatin + Ezetimibe and Simvastatin (3 arms). Primary endpoint: Major Atherosclerotic Events at 4.9 years. Started Jun 2003; status: completed.
02
Drugs
simvastatinezetimibe
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00125593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125593.